PharmacyCodes



Cefadroxil Micronised Powder en es it fr

Categorie

Cefadroxil Micronised Powder Les marques, Cefadroxil Micronised Powder Analogs

Cefadroxil Micronised Powder Les marques melange

  • None

    • Cefadroxil Micronised Powder Formule chimique

    C16H17N3O5S

    Cefadroxil Micronised Powder RX lien

    http://www.rxlist.com/cgi/generic/cefadrox.htm

    Cefadroxil Micronised Powder FDA fiche

    Cefadroxil Micronised Powder msds (fiche de securite des materiaux)

    Cefadroxil Micronised Powder Synthese de reference

    LB Crast, Jr., le brevet américain. 3,489,752 (1969)

    Cefadroxil Micronised Powder Poids moleculaire

    363.389 g/mol

    Cefadroxil Micronised Powder Point de fusion

    197oC

    Cefadroxil Micronised Powder H2O Solubilite

    1110 mg / L

    Cefadroxil Micronised Powder Etat

    Solid

    Cefadroxil Micronised Powder LogP

    -0.355

    Cefadroxil Micronised Powder Formes pharmaceutiques

    Capsule; Tablet; orale liquide

    Cefadroxil Micronised Powder Indication

    Pour le traitement des infections suivantes (peau, infections urinaires, ORL) causés par: S. pneumoniae, H. influenzae, staphylocoques, S. pyogenes (streptocoques du groupe A bêta-hémolytique), E. coli, P. mirabilis, Klebsiella sp, staphylocoques à coagulase négative et Streptococcus pyogenes

    Cefadroxil Micronised Powder Pharmacologie

    Cefadroxil, un antibiotique céphalosporine de première génération, est utilisé pour traiter les infections urinaires, infections structure de la peau et la peau, la pharyngite et l'amygdalite.

    Cefadroxil Micronised Powder Absorption

    Cefadroxil est bien absorbée sur l'administration orale, l'alimentation ne pas interférer avec l'absorption.

    Cefadroxil Micronised Powder Toxicite

    Nausées, vomissements, diarrhée, éruptions cutanées allergiques peuvent se produire

    Cefadroxil Micronised Powder Information pour les patients

    Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

    Cefadroxil Micronised Powder Organismes affectes

    Bactéries entériques et d'autres eubactéries